Protalix BioTherapeutics (PLX) EBT Margin Growth (1y) (2011 - 2026)
Protalix BioTherapeutics (PLX) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | 9,954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,954.00 |
| Dec 31, 2025 | -10,620.00 |
| Sep 30, 2025 | -886.00 |
| Jun 30, 2025 | 2,108.00 |
| Mar 31, 2025 | 8,938.00 |
| Dec 31, 2024 | 27,543.00 |
| Sep 30, 2024 | 3,802.00 |
| Jun 30, 2024 | -7,288.00 |
| Mar 31, 2024 | -9,566.00 |
| Dec 31, 2023 | -17,306.00 |
| Sep 30, 2023 | 853.00 |
| Jun 30, 2023 | 11,695.00 |
| Mar 31, 2023 | -1,641.00 |
| Dec 31, 2022 | 3,092.00 |
| Sep 30, 2022 | 1,048.00 |
| Jun 30, 2022 | 11,596.00 |
| Mar 31, 2022 | 3,756.00 |
| Dec 31, 2021 | -9,713.00 |
| Sep 30, 2021 | 658.00 |
| Jun 30, 2021 | -13,871.00 |